Autoantibodies to Select Brain Regions in Autism by Rivas, Wyatt Harlan
Utah State University 
DigitalCommons@USU 
Undergraduate Honors Capstone Projects Honors Program 
5-2003 
Autoantibodies to Select Brain Regions in Autism 
Wyatt Harlan Rivas 
Utah State University 
Follow this and additional works at: https://digitalcommons.usu.edu/honors 
 Part of the Biology Commons 
Recommended Citation 
Rivas, Wyatt Harlan, "Autoantibodies to Select Brain Regions in Autism" (2003). Undergraduate Honors 
Capstone Projects. 856. 
https://digitalcommons.usu.edu/honors/856 
This Thesis is brought to you for free and open access by 
the Honors Program at DigitalCommons@USU. It has 
been accepted for inclusion in Undergraduate Honors 
Capstone Projects by an authorized administrator of 
DigitalCommons@USU. For more information, please 
contact digitalcommons@usu.edu. 
AUTOANTIBODIES TO SELECT BRAIN REGIONS IN AUTISM 
Approved: 
By 
Wyatt Harlan Rivas 
Thesis submitted in partial fulfillment 
of the requirements for the degree 
of 
UNIVERSITY HONORS 
WITH DEPARTMENT HONORS 
in 
Biology 
Thesis/Project Advisor Department Honors Advisor 
Director of Honors Program 
UTAH STATE UNIVERSITY 
Logan, Utah 
2003 
AUTOANTIBODIES TO SELECT BRAIN REGIONS IN AUTISM 
Wyatt H. Rivas 
Introductory Statement: 
My honor's project involved research, determining specific brain regions 
affected by autoantibodies in autism, under Dr. Vijendra K. Singh in the 
Department of Biology over a one-year period. During that time, I've been 
exposed to a wide variety of bench research methods and protocols. As part of 
the undergraduate research training, I also received training in laboratory safety 
and blood-borne pathogen handling and was certified by the Environmental 
Health and Safety Center on campus. The whole experience has been a wide 
eye opener. I've learned a tremendous amount, namely skills and knowledge 
that I'll carry with me throughout my career, under the tutelage of Dr. Singh. I 
presented our research on April 1 yth at the annual 2003 student showcase (See 
miniature version of the poster on next page). The following is a description of 
our research. 
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ABSTRACT: 
Autism, a neurodevelopmental disorder, may involve abnormal immune 
reaction such as autoimmunity to the brain. Autoimmunity is generally 
characterized by the presence of organ-specific autoantibodies, for example the 
brain-specific autoantibodies in autism. Thus, we conducted a study of 
autoantibodies against three brain regions, including the caudate-putamen 
nucleus (CP), cerebral cortex (CC), and cerebellum (CE). These brain regions 
were dissected out from the brain of a Sprague-Dawley rat and homogenized for 
protein separation by SOS-PAGE. Autoantibodies were detected by 
immunoblotting technique in the serum of autistic children (n=42) and normal 
children (n=11 ). We found that many autistic children had autoantibodies to 
neural proteins: 46% of sera were positive for CP, 20% of sera were positive for 
CC, and 2% of sera were positive for CE. Normal children did not harbor these 
autoantibodies. Because of the highest number of autistic sera positive for 
autoantibodies to CP, we suggest that the caudate-putamen nucleus might be 
affected in the brain of autistic children. Subsequently, we made a supernatant 
(CPS) of the CP homogenate and repeated immunoblotting assays for 
autoantibodies. We detected autoantibodies to three proteins of the CPS with 
molecular weights of approximately 160 kD, 115 kD and 49 kD. The nature of 
these proteins is currently under investigation. 
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INTRODUCTION: 
Autism is an early-onset disorder of the developing central nervous 
system (CNS). The disorder causes severe deficits of higher mental functions 
such as social interaction, language, communication, imagination and cognition. 
Today, autism is the fastest-growing developmental disability [1 ]. Autism affects 
more than one-half of a million Americans and millions more worldwide but very 
little is known about the etiology and pathogenesis of the disorder. 
Current theories include genetic factors, immune factors, environmental 
factors and yet other unidentified factors [2,3]. We focused on immune factors 
such as autoimmunity in autism [4,5]. Indeed, the evidence is rapidly 
accumulating to support an "autoimmune hypothesis" in autism, as recently 
described in a review article [6]. Autoimmunity in autistic children is shown by 
several autoimmune factors: brain-specific autoantibodies [2,3,7], impaired 
lymphocyte functions [8-11], abnormal cytokine regulation [6], viral associations 
[12] and indirect association of certain immunogenetic factors [13]. 
In the present study, our goal was to determine if autistic children harbor 
brain-specific autoantibodies particularly with regards to different brain regions. 
This study is an extension of a pilot study previously conducted in Dr. Singh's 
laboratory [14]. Based on the known neurobiology of autism, we selected three 
brain regions: Cerebellum (CE), Cerebral Cortex (CC), and Caudate-Putamen 
(CP) nucleus (See Figure 1 ). Laboratory studies described here provide initial 
evidence for an autoimmune reaction to caudate nucleus in children with autistic 
disorder. 
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Figure 1: Showing Three Brain Regions Selected in the Study 
Cerebral Cortex (CC) Caudate Putamen (CP) 
Cerebellum (CE) 
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MATERIALS AND METHODS: 
1. Subjects: The study included a total of 53 children: (i) 42 Autistic children; and 
(ii) 11 Normal children. Of the 42 autistic children, 5 had a diagnosis of pervasive 
developmental disorder (POD) and 37 had a diagnosis of autism. The clinical 
diagnosis of autism was made essentially according to the standard DSM-IV 
criteria of the American Association of Psychiatrists, Washington, DC. The 
Institutional Review Board (IRB) of Utah State University reviewed and approved 
our research protocol that involved the use of human blood samples. 
2. Brain Autoantibody Detection: This was performed essentially according to 
our published methods of immunoblotting technique [4,5, 12]. A Sprague-Dawley 
rat was sacrificed to remove brain. Then the brain was dissected to collect 
caudate-putamen (CP), cerebral cortex (CC) and cerebellum (CE). Their location 
in the human brain is diagramatically shown in Figure 1. Each brain region was 
separately homogenized in Tween-20 containing Tris-Buffered Saline (TBST) 
and stored frozen. Later on in the study, the CP homogenate was centrifuged in 
a microcentrifuge to make CP supernatant (CPS). 
3. Protein Electrophoresis & Transfer: The separate brain regions were each 
combined with a 4X sample buffer in a microcentrifuge tube and boiled for five 
minutes and then allowed to cool. Using a micropipette, 100 microliter aliquots 
were placed in a long horizontal well along the top of the gels. Standards were 
also placed in side wells. The electrophoresis apparatus was turned on and the 
proteins migrated down the gel with the help from a 150 mV current for about an 
7 
hour. The individual proteins were separated out by molecular weight, larger 
proteins move slower, during this step. The proteins were then transferred onto 
nitrocellulose membranes (NCMs). To do this, each gel was sandwiched on 
either side by a sponge, blotting paper, and NCM (See "Sandwich" diagram). 
After securing the sandwich they were placed in a transfer buffer and left for 20-
24 hours. The NCM's were dried and then blocked for a minimum of 2 hours by 
soaking in 100 ml of TBST buffer (Tris-Buffered Saline Tween) containing 1 % 
(w/v) bovine serum albumin (BSA). 
4. Immunoassay: The NCMs, after blocking with BSA, were used for antibody 
detection by our standard immunoblotting procedure. The NCMs were cut into 
narrow blots (3-4 mm wide) and placed in a 1 :25 pre-dilution serum/ TBS. After 
incubation for an hour the blots were washed three times with TBST. Then they 
were incubated in the presence of the secondary antibody that was alkaline 
phosphatase-conjugated-goat-antihuman immunoglobulins (pre-diluted at 
1 :2,500). This is a polyvalent antibody that contains lgG, lgM and lgA. Again 
this was allowed to incubate for an hour and again washed three times with 
TBST. The blots were incubated in the color reagent (AP substrate reagent 
purchased from Bio-Rad Labs.) and the color was allowed to develop. A reaction 
was scored positive if a purplish-blue band appeared (See Figure 2). During the 
experiment, all serum samples were treated the same. To prevent potential bias, 
all samples were analyzed in a double-blind fashion and the code was broken 









RESULTS and DISCUSSION: 
At first, the brain proteins of CP, CC and CE were separated from different 
regions and transferred to nitrocellulose membranes. This was followed by 
immunoassays in the presence of patient or control serum, which served as the 
source of autoantibody. The representative positive reactions are shown in 
Figure 2. Autistic serum showed a positive reaction but normal serum did not. 
The autoantibody screen revealed that the highest number of autoantibody-
positive autistic sera was with the CP region (46%) as compared to CC region 
(20%) or CE region (2%) (Figure 3). This finding suggests that the neurons in 
the caudate nucleus (CP) might be a target of autoimmune pathology in autism 
but more research is necessary to firmly establish this observation. 
Because CP region was the most immunoreactive region, an attempt was 
made to extract proteins from this brain region followed by immunoblotting. First, 
the protein patterns of CP homogenate and CP supernatant (CPS) were 
resolved. The protein patterns of CP (Figure 4a) and CPS (Figure 4b) resembled 
quite closely. Then, the immunoassay with autistic sera showed that they were 
positive for two major proteins in CP (Figure 5); they had molecular weights of 
approximately 160,000 and 115,000 (Figure 6a). These two proteins also showed 
positive reaction in CPS but an additional protein band was positive at a 
molecular weight of approximately 49,000 (Figure 5 & 6b). Considering the fact 
that CP and CPS contain a large number of proteins, it is interesting to find only 
two or three proteins showing autoantibody positive reactions in autistic children. 
This must imply a significant level of specificity with respect to the proteins of the 
CP region. Once they have been fully characterized, these proteins could 
potentially serve as markers of neuropathology in autism. This aspect of brain-
autoimmunity and autism research is currently under investigation in Dr. Singh's 
laboratory. In summary, the key findings of this study are: 
1. We found that approximately 46% of autistic children but none of the 
normal children harbored brain-specific autoantibodies, in particular 
autoantibodies to caudate nucleus of the brain. 
2. Approximately 20% of autistic children also had antibodies to cerebral 
cortex. Normal children did not harbor these antibodies. 
3. Only one out of 37 autistic children (a very low number of positive sera) 
had antibodies to cerebellum. 
4. In the caudate nucleus, the immunoreactive proteins showed approximate 
molecular weights of 160 kD, 115 kD and 49 kD. 
CONCLUSION: 
We detected a significant percentage of autoantibodies to the caudate 
nucleus of the brain in autistic children, and none in normal children. Three 
unique caudate nucleus proteins were isolated and molecular weights 
determined. This is the first study of this kind. This new immunological 
evidence may suggest the involvement of caudate nucleus in the 
neuropathology of autism. 
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FIGURE 2 
Normal Autistic Normal Autistic Normal Autistic 
Serum Serum Serum Serum Serum Serum 
Caudate Putamen (CP) Cerebral Cortex (CC) Cerebellum (CE) 
Figure 2. Typical immunoblots of CP, CC, and CE autoantibodies: Note that the 
black arrows are pointing to positive bands due to antibodies in autistic children 
but not in normal children. 
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FIGURE 3 
Antibody Distribution in Brain Regions 
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Caudate Nucleus Cerebra12Cortex Cerebellum 
Brain Regions 
Figure 3. Distribution of brain autoantibodies in three different brain 
regions. Note that the highest number of autistic sera (17/37) were 
positive for CP proteins but not for CC or CE proteins. 
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FIGURE 4a & 4b 
! == 
C == 
/ Fig. 4a. CP gel showing Protein Pattern 
-6 6 




Autistic Sera Autistic Sera 
Caudate Putamen (CP) ➔➔➔ Caudate Putamen 
Supernatant (CPS) 
Figure 5. Representative CP& CPS immunoblots reacted with autistic sera. 
Note that black arrows point to positive reactions. These bands corresponded to 
proteins of 160 kD, 115 kD and 49 kD molecular weights as shown in Figures 6a 
& 6b on the next page). 
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FIGURE 6a & 6b 
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2 3 4 5 6 7 
Relative migration (mm) 
Figure 6a & 6b. Molecular weight determination of CP and CPS Proteins 
immuno-reactive for autoantibodies. Note that autoantibodies reacted to two 
major proteins (160 kD and 115 kD) in both CP (Fig.6a) and CPS (Fig. 6b), plus 
a third protein (49 kD) in CPS only. 
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